fury of odin megaways png Novartis acquires global rights to Merck's new drug pipeline for 450 million euros One place allows village doctors to use non-basic drugs Fosun Pharma: Hanlin ...

INR:3219. australia cricket team vs england cricket team match scorecard Merck and Dinghang reach a collaboration t ...

beware the deep megaways png 8 provinces have determined the time for the expansion of the "4+7" policy! Two core issues remain to be resolved Seven more patents granted! Merck's total number of ...

INR:4996. casino free sign up bonus Unlocking a new target for the treatment of deadly lung cancer, a diabetes drug candidate may have a miraculous effe ...

MSD plans to submit the data from the trials to regulatory authorities for review. Credit: © 2024 Merck & Co. US-based pharmaceutical company MSD has reported ...

Merck's DOR/ISL regimen demonstrated non-inferiority to bART and BIC/FTC/TAF in two pivotal Phase 3 trials for adults with HIV-1. Both trials achieved primary safety objectives, with detailed ...

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion. Under the terms of the deal, the company will gain the exclusive global ...

Merck (NYSE:MRK) and Chinese biopharmaceutical company Hansoh Pharma (OTCPK:HNSPF) announced a global licensing deal on Wednesday to develop HS-10535, an oral GLP-1 receptor agonist targeted at ...

Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. Merck will pay Hansoh $112 million ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a preclinical drug. The Big Pharma already has efinopegdutide, a dual GLP-1 ...